Recent Analyst Stock Rating News
The Best Trading Research Platform
For Retail Investors and Professional Trades Alike.Get Started for Free
Thomas Shrader is an analyst at BTIG. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 03/25/2025
| Buy Now | Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| 03/24/2025 | OVID | Buy Now | Ovid Therapeutics | $0.46 | 762.81% | Thomas Shrader43% | $5 → $4 | Maintains | Buy | Get Alert |
| 01/28/2025 | ARCT | Buy Now | Arcturus Therapeutics | $12.77 | 221.06% | Thomas Shrader43% | → $41 | Initiates | → Buy | Get Alert |
| 11/26/2024 | ALEC | Buy Now | Alector | $1.31 | 281.65% | Thomas Shrader43% | $16 → $5 | Maintains | Buy | Get Alert |
| 09/04/2024 | ATHA | Buy Now | Athira Pharma | $0.35 | — | Thomas Shrader43% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/03/2024 | PCVX | Buy Now | Vaxcyte | $71.90 | 122.53% | Thomas Shrader43% | $98 → $160 | Maintains | Buy | Get Alert |
| 08/07/2024 | PCVX | Buy Now | Vaxcyte | $71.90 | 122.53% | Thomas Shrader43% | $160 → $160 | Reiterates | Buy → Buy | Get Alert |
| 08/07/2024 | PCVX | Buy Now | Vaxcyte | $71.90 | 36.3% | Thomas Shrader43% | $98 → $98 | Reiterates | Buy → Buy | Get Alert |
| 06/18/2024 | OVID | Buy Now | Ovid Therapeutics | $0.46 | 978.52% | Thomas Shrader43% | $11 → $5 | Maintains | Buy | Get Alert |
| 05/31/2024 | ACIU | Buy Now | AC Immune | $2.02 | 296.04% | Thomas Shrader43% | → $8 | Initiates | → Buy | Get Alert |
| 12/21/2023 | OVID | Buy Now | Ovid Therapeutics | $0.46 | 2272.74% | Thomas Shrader43% | → $11 | Initiates | → Buy | Get Alert |
| 10/03/2023 | PMN | Buy Now | ProMIS Neurosciences | $0.64 | 1150% | Thomas Shrader43% | → $8 | Initiates | → Buy | Get Alert |
| 07/28/2023 | DTIL | Buy Now | Precision BioSciences | $5.12 | -60.91% | Thomas Shrader43% | $180 → $60 | Maintains | Buy | Get Alert |
| 06/30/2023 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Thomas Shrader43% | — | Downgrade | Buy → Neutral | Get Alert |
| 06/06/2023 | BHVN | Buy Now | Biohaven | $29.87 | -6.26% | Thomas Shrader43% | $24 → $24 | Reiterates | → Buy | Get Alert |
| 05/25/2023 | ANNX | Buy Now | Annexon | $2.60 | 169.31% | Thomas Shrader43% | $15 → $7 | Maintains | Buy | Get Alert |
| 05/18/2023 | COYA | Buy Now | Coya Therapeutics | $6.70 | 123.88% | Thomas Shrader43% | → $15 | Initiates | → Buy | Get Alert |
| 03/30/2023 | ATHA | Buy Now | Athira Pharma | $0.35 | 2757.14% | Thomas Shrader43% | $33 → $10 | Maintains | Buy | Get Alert |
| 03/28/2023 | BCAB | Buy Now | BioAtla | $0.38 | 3366.67% | Thomas Shrader43% | $68 → $13 | Maintains | Buy | Get Alert |
| 03/20/2023 | VRNA | Buy Now | Verona Pharma | $66.65 | -53.49% | Thomas Shrader43% | $26 → $31 | Maintains | Buy | Get Alert |
| 03/02/2023 | ALEC | Buy Now | Alector | $1.31 | 1121.28% | Thomas Shrader43% | $54 → $16 | Maintains | Buy | Get Alert |
| 12/20/2022 | VRNA | Buy Now | Verona Pharma | $66.65 | -60.99% | Thomas Shrader43% | $17 → $26 | Maintains | Buy | Get Alert |
| 12/02/2022 | BHVN | Buy Now | Biohaven | $29.87 | -19.65% | Thomas Shrader43% | → $24 | Initiates | → Buy | Get Alert |
| 11/17/2022 | PCVX | Buy Now | Vaxcyte | $71.90 | -4.03% | Thomas Shrader43% | → $69 | Initiates | → Buy | Get Alert |
| 11/14/2022 | GANX | Buy Now | Gain Therapeutics | $2.25 | 344.44% | Thomas Shrader43% | $30 → $10 | Maintains | Buy | Get Alert |
| 10/06/2022 | SQZ | Buy Now | SQZ Biotechnologies | — | — | Thomas Shrader43% | $400 → $150 | Maintains | Buy | Get Alert |
| 10/05/2022 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 1718.18% | Thomas Shrader43% | $15 → $22 | Maintains | Buy | Get Alert |
| 09/09/2022 | ANNX | Buy Now | Annexon | $2.60 | 477.1% | Thomas Shrader43% | → $15 | Initiates | → Buy | Get Alert |
| 07/15/2022 | ABOS | Buy Now | Acumen Pharmaceuticals | $1.21 | 1139.67% | Thomas Shrader43% | → $15 | Initiates | → Buy | Get Alert |
| 05/24/2022 | INMB | Buy Now | INmune Bio | $8.96 | 56.29% | Thomas Shrader43% | $31 → $14 | Maintains | Buy | Get Alert |
| 05/10/2022 | ATHA | Buy Now | Athira Pharma | $0.35 | 9328.57% | Thomas Shrader43% | → $33 | Initiates | → Buy | Get Alert |
| 10/29/2021 | SGTX | Buy Now | Sigilon Therapeutics | — | — | Thomas Shrader43% | → $182 | Initiates | → Buy | Get Alert |
| 04/20/2021 | PLRX | Buy Now | Pliant Therapeutics | $1.52 | 3255.48% | Thomas Shrader43% | → $51 | Initiates | → Buy | Get Alert |
| 04/12/2021 | GANX | Buy Now | Gain Therapeutics | $2.25 | 1233.33% | Thomas Shrader43% | → $30 | Initiates | → Buy | Get Alert |
| 03/26/2021 | BCAB | Buy Now | BioAtla | $0.38 | 23100% | Thomas Shrader43% | $47 → $87 | Maintains | Buy | Get Alert |
| 03/26/2021 | GXGX | Buy Now | GX Acquisition | — | — | Thomas Shrader43% | → $16 | Initiates | → Buy | Get Alert |
| 03/08/2021 | ONCS | Buy Now | OncoSec Medical | — | — | Thomas Shrader43% | → $220 | Initiates | → Buy | Get Alert |
| 03/08/2021 | NUVB | Buy Now | Nuvation Bio | $1.92 | 732.86% | Thomas Shrader43% | → $16 | Initiates | → Buy | Get Alert |
| 02/03/2021 | VYGR | Buy Now | Voyager Therapeutics | $3.76 | — | Thomas Shrader43% | — | Downgrade | Buy → Neutral | Get Alert |
| 01/11/2021 | BCAB | Buy Now | BioAtla | $0.38 | 12433.33% | Thomas Shrader43% | → $47 | Initiates | → Buy | Get Alert |
| 11/24/2020 | SQZ | Buy Now | SQZ Biotechnologies | — | — | Thomas Shrader43% | → $400 | Initiates | → Buy | Get Alert |
| 11/18/2020 | EIDX | Buy Now | Eidos Therapeutics | — | — | Thomas Shrader43% | — | Downgrade | Buy → Neutral | Get Alert |
| 10/16/2020 | DNLI | Buy Now | Denali Therapeutics | $14.58 | — | Thomas Shrader43% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/23/2020 | VCNX | Buy Now | Vaccinex | $0.95 | — | Thomas Shrader43% | — | Downgrade | Buy → Neutral | Get Alert |
| 09/15/2020 | ETNB | Buy Now | 89bio | $7.99 | 625.91% | Thomas Shrader43% | $51 → $58 | Maintains | Buy | Get Alert |
| 09/01/2020 | INMB | Buy Now | INmune Bio | $8.96 | 156.77% | Thomas Shrader43% | → $23 | Initiates | → Buy | Get Alert |
| 09/01/2020 | CMPI | Buy Now | Checkmate Pharmaceuticals | — | — | Thomas Shrader43% | → $29 | Initiates | → Buy | Get Alert |
| 04/03/2020 | GERN | Buy Now | Geron | $1.70 | 76.47% | Thomas Shrader43% | $4 → $3 | Maintains | Buy | Get Alert |
| 08/09/2019 | DNLI | Buy Now | Denali Therapeutics | $14.58 | 105.76% | Thomas Shrader43% | → $30 | Initiates | → Buy | Get Alert |
| 08/02/2019 | ACOR | Buy Now | Acorda Therapeutics | — | — | Thomas Shrader43% | $1440 → $840 | Maintains | Hold | Get Alert |
| 04/18/2019 | EIDX | Buy Now | Eidos Therapeutics | — | — | Thomas Shrader43% | → $38 | Initiates | → Buy | Get Alert |
| 02/21/2019 | BIIB | Buy Now | Biogen | $139.16 | 148.63% | Thomas Shrader43% | $397 → $346 | Downgrade | Buy → Hold | Get Alert |
| 02/13/2019 | GERN | Buy Now | Geron | $1.70 | 135.29% | Thomas Shrader43% | → $4 | Initiates | → Buy | Get Alert |
| 08/07/2018 | ACOR | Buy Now | Acorda Therapeutics | — | — | Thomas Shrader43% | $1800 → $3000 | Maintains | Hold | Get Alert |
| 08/07/2018 | BIIB | Buy Now | Biogen | $139.16 | 183.13% | Thomas Shrader43% | → $394 | Reinstates | → Buy | Get Alert |
| 02/22/2018 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Thomas Shrader43% | — | Upgrade | Hold → Buy | Get Alert |
| 11/16/2017 | ACOR | Buy Now | Acorda Therapeutics | — | — | Thomas Shrader43% | — | Downgrade | Buy → Hold | Get Alert |
| 10/27/2017 | Q | Buy Now | Quintiles IMS Holdings | — | — | Thomas Shrader43% | — | Upgrade | Hold → Buy | Get Alert |
| 10/17/2017 | BIIB | Buy Now | Biogen | $139.16 | — | Thomas Shrader43% | — | Upgrade | Hold → Buy | Get Alert |
| 10/05/2017 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Thomas Shrader43% | — | Downgrade | Buy → Hold | Get Alert |
| 10/04/2017 | MNTA | Buy Now | Momenta Pharmaceuticals | — | — | Thomas Shrader43% | — | Downgrade | Buy → Hold | Get Alert |
| 06/30/2017 | WINT | Buy Now | Windtree Therapeutics | $1.64 | — | Thomas Shrader43% | — | Downgrade | Buy → Hold | Get Alert |
| 05/22/2017 | VRNA | Buy Now | Verona Pharma | $66.65 | -66.99% | Thomas Shrader43% | → $22 | Initiates | → Buy | Get Alert |
| 05/08/2017 | TOCA | Buy Now | Tocagen | — | — | Thomas Shrader43% | — | Initiates | → Buy | Get Alert |
| 03/03/2017 | KITE | Buy Now | Kite Pharma | — | — | Thomas Shrader43% | — | Downgrade | Buy → Hold | Get Alert |
| 08/19/2016 | GERN | Buy Now | Geron | $1.70 | — | Thomas Shrader43% | — | Initiates | → Neutral | Get Alert |
| 03/04/2016 | GI | Buy Now | EndoChoice Holdings | — | — | Thomas Shrader43% | $16 → $10 | Maintains | Buy | Get Alert |
| 03/04/2016 | ARMH | Buy Now | ARM Holdings | — | — | Thomas Shrader43% | — | Downgrade | Buy → Hold | Get Alert |
| 03/04/2016 | VTAE | Buy Now | Vitae Pharmaceuticals | — | — | Thomas Shrader43% | — | Downgrade | Buy → Hold | Get Alert |
